The placebo effect in horses refers to the phenomenon where a horse experiences a perceived or actual improvement in condition following a treatment that has no therapeutic effect. This effect is often observed in clinical trials and studies where control groups receive a placebo treatment to assess the efficacy of a new drug or therapy. Understanding the placebo effect in horses is important for designing rigorous equine research studies, as it helps distinguish between the actual effects of a treatment and psychological or physiological responses that are not directly caused by the treatment itself. This page compiles peer-reviewed research studies and scholarly articles that explore the mechanisms, implications, and methodologies for accounting for the placebo effect in equine research.
Milne DW, Gabel AA, Muir WW, Skarda RT, Hamlin RL, Pipers FS.In a double-blind study under simulated racing conditions, six Standardbred horses, which had been trained for 12 weeks, were given 1 mg of furosemide/kg of body weight or saline solution IV 15 minutes before the first of two warm-up workouts (1.6 km at 60-minute intervals). Sixty minutes later, 135 minutes after drug or placebo injection, these horses were driven 1.6 km at maximum speed. Heart rate, respiratory rate, cardiac output, pulmonary trunk pressure, body temperature, PCV, arterial oxygen, and plasma lactic acid were recorded during and after the first warm-up workout and after a simu...
Coffman JR, Johnson JH, Tritschler LG, Garner HE, Scrutchfield WL.Fourteen horses (7 treated with orgotein and 7 treated with a placebo) with navicular disease were studied on a double blind basis. All 14 horses had clinical and radiographic evidence of navicular disease. Orgotein and the placebo were administered by juxtabursal injection. Of the 7 orgotein-treated horses, 3 responded but none of the 7 placebo-treated horses responded. The difference was statistically significant (P less than 0.05).
Boudreault A, Boulay G, Marois P, Pavilanis V.Live human and equine influenza virus strains modified by serial passage on allantois-on-shell system (AOS) in the presence of normal horse serum were administered orally or intranasally to volunteers or horses. Mostly mild clinical short-lasting reactions, replication in nasal mucosae, transmission to placebo recipients and significant local or circulating antibody rises were observed following administration to volunteers of strains modified by five or less serial passages on AOS in the presence of normal horse serum (NHS). Milder clinical reactions, no replication, no viral transmission and...
Degenerative joint disease is one of the main causes of equine early retirement from pleasure riding or a performance career. The disease is initially triggered by an abnormal loading of normal cartilage or a normal loading of abnormal cartilage. This primary insult is accompanied with joint inflammation, which leads to further progressive degeneration of the articular cartilage and changes in the surrounding tissues. Therefore, in search for an effective treatment, 75 adult horses with early signs of degenerative fetlock joint disease were enrolled in a randomized, multicenter, double-blinded...
Michanek P, Bröjer J, Lilliehöök I, Fjordbakk C, Erkas M, Löwgren M, Hedeland M, Bergquist J, Ekstrand C.Sodium-glucose co-transporter 2 inhibitors like canagliflozin (CFZ) have shown promise in preventing hyperinsulinemia-associated laminitis in horses, but data on pharmacokinetics, tolerability, and controlled studies are limited. This randomized, open-label, placebo-controlled, crossover study evaluated these aspects of CFZ treatment in eight healthy Standardbred mares. Each horse received single supratherapeutic oral doses of CFZ (1.8 mg/kg or 3.6 mg/kg) and placebo, with a two-week washout between treatments. A graded glucose infusion (GGI) was administered post-treatment to evaluate glu...
Norton EM, Plumb S, Shane D, Smalley L, McKendry K, Scharf B, Zemel M.Supplements claiming to improve metabolic profiles in equine metabolic syndrome (EMS) often lack scientific validation. Objective: To evaluate the effect of a supplement containing leucine, resveratrol and pyridoxine on the metabolic profile in ponies with EMS. Methods: Unmasked randomised, placebo-controlled field trial. Methods: Thirty-eight ponies completed the trial across five farms. Ponies were age and sex matched per farm and randomly assigned to the supplement (n = 20) or placebo group (n = 18) with owners masked to group assignments. Ponies were sampled at days -1/0 (T1), 7/8 ...
Hansen S, Tecles F, Cerón JJ, From C, Carstensen H, Muñoz-Prieto A.The number of horses with equine squamous gastric disease (ESGD) and equine gastric glandular disease (EGGD) recurrence when pharmacological treatment is discontinued is high. Objective: To examine if a commercially available nutraceutical compound containing lecithin, pectin, and meadowsweet could prevent recurrence of both ESGD and EGGD after omeprazole treatment, evaluated by repeated gastroscopic examinations and saliva biomarkers. Methods: Blinded, randomised, placebo-controlled clinical trial. Methods: Thirty horses of mixed breeds and sex with a recent diagnosis and treatment of both ES...
Brandenberger O, Kalinovskiy A, Körner J, Genn H, Burger R, Leser S.The use of Bio-Electro-Magnetic-Energy-Regulation (BEMER) therapy during general anesthesia has not previously been reported in horses. This randomized, investigator-blinded, placebo-controlled trial evaluates equine cardiopulmonary function and recovery quality after BEMER therapy application for 15 min in 100 horses during general anesthesia using isoflurane for pars-plana vitrectomy surgery as treatment for recurrent uveitis. Visually identical blankets were used in the two groups (1:1 ratio), one with a functional BEMER module and the other with a placebo module. Arterial blood pressure, b...